MedTrace Logo

Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China

NCT01525693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2013-02-15

No results posted yet for this study

Summary

This is a study to gain better understanding on how those patients who are newly diagnosed with type 2 diabetes are treated and monitored. The study will record information such as type of therapy, therapeutic outcomes, and patients' satisfaction.

Conditions

Sponsors & Collaborators

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • VitalStrategic Research Institute

    collaborator OTHER

  • China Cardiometabolic Registries

    lead NETWORK

Principal Investigators

  • Linong Ji, MD · Peking University People's Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-10-31
Completion
2014-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01525693 on ClinicalTrials.gov